Greg Beattie joined Inotiv on February 15, 2021, bringing more than 30 years of contract research experience to the company, including more than two decades in operational leadership roles at Charles River Laboratories, where he drove growth and profitability across multiple business units. During his career at CRL, Beattie held corporate vice president positions leading business units within all three of Charles River Laboratories’ segments of operations (Discovery and Safety Assessment, Research Models and Services, and Manufacturing Support). In these roles, he was responsible for driving operational performance for divisions with revenue in excess of $100 million.
Among his most significant accomplishments was leadership of the design, construction, and staffing of one of the largest preclinical facilities in the world in Reno, Nevada. Beattie also led a new business venture (Charles River Accelerator and Development Lab) and integrated an expanding biologics testing solutions business.
Beattie holds a Bachelor of Science degree in Biology from McGill University and a Master of Science degree in Experimental Health Sciences from Université du Quebéc, and graduated from the Kellogg Management Institute program at Northwestern University. He held certification as diplomate of the American Board of Toxicology (DABT) between 1999 and 2019.